Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujun Xing

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cancer Letters|June 2, 2024
Exosome-based anticancer vaccines: From Bench to bedsideGuo Zhao, Yuning Wang, Shujun Xing, et al.
Med (New York, N.Y.)|May 10, 2025
Learning from the LEAP trial series: Optimizing clinical trial design for combination therapiesJiatong Ding, Yue Yu, Dandan Cui, et al.
EMBO Molecular Medicine|August 25, 2021
The state of the art of bispecific antibodies for treating human malignanciesShuhang Wang, Kun Chen, Qi Lei, et al.
Brain : a Journal of Neurology|November 8, 2024
Bridging the gap: unlocking the potential of emerging drug therapies for brain metastasisJiatong Ding, Yale Jiang, Ning Jiang, et al.
BMJ Open|June 4, 2021
Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumoursShuhang Wang, Hui-Yao Huang, Dawei Wu, et al.
Cancer Cell|January 12, 2021
The Landscape of Cell and Gene Therapies for Solid TumorsShuhang Wang, Fa Sun, Huiyao Huang, et al.
The Lancet Regional Health. Western Pacific|November 25, 2022
The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challengesHuiyao Huang, Yu Tang, Yue Yu, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cancer Letters|June 2, 2024
Exosome-based anticancer vaccines: From Bench to bedsideGuo Zhao, Yuning Wang, Shujun Xing, et al.
Med (New York, N.Y.)|May 10, 2025
Learning from the LEAP trial series: Optimizing clinical trial design for combination therapiesJiatong Ding, Yue Yu, Dandan Cui, et al.
EMBO Molecular Medicine|August 25, 2021
The state of the art of bispecific antibodies for treating human malignanciesShuhang Wang, Kun Chen, Qi Lei, et al.
Brain : a Journal of Neurology|November 8, 2024
Bridging the gap: unlocking the potential of emerging drug therapies for brain metastasisJiatong Ding, Yale Jiang, Ning Jiang, et al.
BMJ Open|June 4, 2021
Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumoursShuhang Wang, Hui-Yao Huang, Dawei Wu, et al.
Cancer Cell|January 12, 2021
The Landscape of Cell and Gene Therapies for Solid TumorsShuhang Wang, Fa Sun, Huiyao Huang, et al.
The Lancet Regional Health. Western Pacific|November 25, 2022
The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challengesHuiyao Huang, Yu Tang, Yue Yu, et al.
Pageof 4